Macrogen Europe is a biotechnology and healthcare company based in The Netherlands. Founded in 2008, the company is committed to sequencing excellence, as indicated by its slogan "Committed to Sequencing Excellence". Macrogen Europe specializes in providing fast and reliable Sanger sequencing, next generation sequencing (NGS), and bioinformatics services to scientists in Europe and Africa. With a focus on speed, accuracy, and scientific excellence, the company works closely with academic and clinical researchers, as well as the biotech industry, to leverage the potential of the genome. The company aims to realize the unlimited potential of genomics research and invites interested parties to reach out at [email protected]. Currently, there is no publicly available information about the company's last investment or its investors.
There is no investment information
No recent news or press coverage available for Macrogen Europe.